SCHEMBL2226032

SCHEMBL2226032

CC(C)S(=O)(=O)c1ccc(S(N)(=O)=O)cc1CNc1cc(Nc2ccc(Cl)cn2)ncn1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRAF P15056 6/20 0.60
TNNI3K Q59H18 9/20 0.49
EGFR P00533 2/20 0.44
MAPK10 P53779 1/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
IDH1 O75874 1/20 0.34
ERBB3 P21860 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226261 0.90 TNNI3K (0.58) BRAFTNNI3KEGFRMAPK10CDK1
SCHEMBL2227068 0.89 CDK1 (0.48) BRAFTNNI3KEGFRCDK1CCNB1
SCHEMBL2225756 0.83 BRAF (0.62) BRAFTNNI3KEGFRCA1CA2
SCHEMBL2225873 0.83 TNNI3K (0.46) BRAFTNNI3KEGFRMAPK10CDK1
SCHEMBL2226387 0.81 BRAF (0.51) BRAFTNNI3KEGFRMAPK10ERBB3
SCHEMBL2227178 0.79 TNNI3K (0.61) BRAFTNNI3KEGFRMAPK10CDK1
SCHEMBL2225876 0.78 BRAF (0.63) BRAFTNNI3KEGFRMAPK10CDK1
SCHEMBL2227374 0.78 CDK1 (0.51) BRAFTNNI3KEGFRCDK1CCNB1
SCHEMBL2226017 0.77 BRAF (0.43) BRAFTNNI3KEGFRCDK1CCNB1
SCHEMBL12517922 0.75 BRAF (1.00) BRAFTNNI3KEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed